A naturally occurring variant in human TLR9, P99L, is associated with loss of CpG oligonucleotide responsiveness.

A naturally occurring variant in human TLR9, P99L, is associated with loss of CpG oligonucleotide responsiveness.

The innate immune system employs Toll-like receptors (TLRs) for the detection of invading microorganisms based on distinct molecular patterns. For example, TLR9 is activated by microbial DNA and also by short therapeutic CpG-containing oligonucleotides (CpG-ODN). TLR9 activation leads to the product...

Bibliografiset tiedot
Päätekijät:	Kubarenko, A, Ranjan, S, Rautanen, A, Mills, T, Wong, S, Vannberg, F, Neumaier, M, Bekeredjian-Ding, I, Hill, A, Ahmad-Nejad, P, Weber, A
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	2010

Samankaltaisia teoksia

Competition by inhibitory oligonucleotides prevents binding of CpG to C-terminal TLR9
Tekijä: Avalos, Ana M., et al.
Julkaistu: (2014)

MyD88 adaptor-like D96N is a naturally occurring loss-of-function variant of TIRAP.
Tekijä: George, J, et al.
Julkaistu: (2010)

Immunotherapeutic Potential of CpG Oligonucleotides in Chickens
Tekijä: Arshud Dar, et al.
Julkaistu: (2009-04-01)

CpG Oligonucleotides as Cancer Vaccine Adjuvants
Tekijä: Hidekazu Shirota, et al.
Julkaistu: (2015-05-01)

Introduction of sugar-modified nucleotides into CpG-containing antisense oligonucleotides inhibits TLR9 activation
Tekijä: Tokuyuki Yoshida, et al.
Julkaistu: (2024-05-01)

The Study of the Therapeutic Effects of CpG Oligonucleotides in Murine Model of Allergic Asthma
Tekijä: T. Mousavi, et al.
Julkaistu: (2007-07-01)

The Study of the Therapeutic Effects of CpG Oligonucleotides in Murine Model of Allergic Asthma
Tekijä: T Mousavi, et al.
Julkaistu: (2007-06-01)

Phosphate-modified CpG oligonucleotides induce in vitro maturation of human myeloid dendritic cells
Tekijä: A. A. Ostanin, et al.
Julkaistu: (2020-10-01)

The Study of the Therapeutic Effects of CpG Oligonucleotides in Murine Model of Allergic Asthma
Tekijä: T Mousavi
Julkaistu: (2012-05-01)

Effect of Calcium Carbonate Encapsulation on the Activity of Orally Administered CpG Oligonucleotides
Tekijä: Neslihan Kayraklioglu, et al.
Julkaistu: (2017-09-01)

In Vivo TLR9 Inhibition Attenuates CpG-Induced Myocardial Dysfunction
Tekijä: O. Boehm, et al.
Julkaistu: (2013-01-01)

The counter regulatory response induced by CpG oligonucleotides prevents bleomycin induced pneumopathy
Tekijä: Kinjo Takeshi, et al.
Julkaistu: (2012-06-01)

Synthetic Hexanucleotides as a Tool to Overcome Excessive Neutrophil Activation Caused by CpG-Containing Oligonucleotides
Tekijä: Ekaterina A. Golenkina, et al.
Julkaistu: (2021-04-01)

Two human MYD88 variants, S34Y and R98C, interfere with MyD88-IRAK4-myddosome assembly.
Tekijä: George, J, et al.
Julkaistu: (2011)

CpG oligonucleotide activates Toll-like receptor 9 and causes lung inflammation in vivo
Tekijä: Hoeft Andreas, et al.
Julkaistu: (2007-10-01)

CpG-containing oligonucleotides are efficient adjuvants for induction of protective antiviral immune responses with T-cell peptide vaccines.
Tekijä: Oxenius, A, et al.
Julkaistu: (1999)

Multiple Immunosuppressive Effects of CpG-c41 on Intracellular TLR-Mediated Inflammation
Tekijä: Wancheng Liu, et al.
Julkaistu: (2017-01-01)

Prophylactic application of CpG oligonucleotides augments the early host response and confers protection in acute melioidosis.
Tekijä: Barbara M Judy, et al.
Julkaistu: (2012-01-01)

CpG Oligonucleotides Protect Mice From Alphavirus Encephalitis: Role of NK Cells, Interferons, and TNF
Tekijä: Mohanraj Manangeeswaran, et al.
Julkaistu: (2020-02-01)

Aberrant methylation of gene associated CpG sites occurs in borderline personality disorder.
Tekijä: Stefanie Teschler, et al.
Julkaistu: (2013-01-01)

Route of administration of the TLR9 agonist CpG critically determines the efficacy of cancer immunotherapy in mice.
Tekijä: Stefan Nierkens, et al.
Julkaistu: (2009-12-01)

The effects of O6-methyl guanine DNA-methyl transferase promotor methylation and CpG1, CpG2, CpG3 and CpG4 methylation on treatment response and their prognostic significance in patients with glioblastoma
Tekijä: Yildiz OG, et al.
Julkaistu: (2020-08-01)

Biophysical Attributes of CpG Presentation Control TLR9 Signaling to Differentially Polarize Systemic Immune Responses
Tekijä: Jardin A. Leleux, et al.
Julkaistu: (2017-01-01)

Cooperative activation of human TLR9 and consequences for the clinical development of antisense and CpG oligodeoxynucleotides
Tekijä: Gunther Hartmann
Julkaistu: (2023-12-01)

Development of CpG-oligodeoxynucleotides for effective activation of rabbit TLR9 mediated immune responses.
Tekijä: Tsung-Hsien Chuang, et al.
Julkaistu: (2014-01-01)

Immunotherapy of Malignant Glioma by Noninvasive Administration of TLR9 Agonist CpG Nano‐Immunoadjuvant
Tekijä: Jingjing Wei, et al.
Julkaistu: (2022-05-01)

In vivo control of CpG and non-CpG DNA methylation by DNA methyltransferases.
Tekijä: Julia Arand, et al.
Julkaistu: (2012-06-01)

pDC Activation by TLR7/8 Ligand CL097 Compared to TLR7 Ligand IMQ or TLR9 Ligand CpG
Tekijä: Jing Wu, et al.
Julkaistu: (2019-01-01)

Prediction of CpG-island function: CpG clustering vs. sliding-window methods
Tekijä: Luque-Escamilla Pedro L, et al.
Julkaistu: (2010-05-01)

The Effect of TLR9 Agonist CpG Oligodeoxynucleotides on the Intestinal Immune Response of Cobia (Rachycentron canadum)
Tekijä: Omkar Byadgi, et al.
Julkaistu: (2014-01-01)

PIKfyve regulates the endosomal localization of CpG oligodeoxynucleotides to elicit TLR9-dependent cellular responses.
Tekijä: Kaoru Hazeki, et al.
Julkaistu: (2013-01-01)

Reliable Detection of DNA CpG Methylation Profiles by the Isoschizomers MspI/HpaII Using Oligonucleotide Stimulators
Tekijä: Dagmar Kupper, et al.
Julkaistu: (1997-11-01)

Antibody Response Following the Intranasal Administration of SARS-CoV-2 Spike Protein-CpG Oligonucleotide Vaccine
Tekijä: Kentaro Muranishi, et al.
Julkaistu: (2023-12-01)

The In Ovo Delivery of CpG Oligonucleotides Protects against Infectious Bronchitis with the Recruitment of Immune Cells into the Respiratory Tract of Chickens
Tekijä: Upasama De Silva Senapathi, et al.
Julkaistu: (2018-11-01)

Alteration of T cell cytokine production in PLPp-139-151-induced EAE in SJL mice by an immunostimulatory CpG Oligonucleotide
Tekijä: Hemmer Bernhard, et al.
Julkaistu: (2011-05-01)

Conformation effects of CpG methylation on single-stranded DNA oligonucleotides: analysis of the opioid peptide dynorphin-coding sequences.
Tekijä: Malik Mumtaz Taqi, et al.
Julkaistu: (2012-01-01)

Low biological fluctuation of mitochondrial CpG and non-CpG methylation at the single-molecule level
Tekijä: Chloe Goldsmith, et al.
Julkaistu: (2021-04-01)

Correlating CpG islands, motifs, and sequence variants in human chromosome 21
Tekijä: Cercone Nick, et al.
Julkaistu: (2011-07-01)

Nanoparticle System Based on Amino-Dextran as a Drug Delivery Vehicle: Immune-Stimulatory CpG-Oligonucleotide Loading and Delivery
Tekijä: Hien V. Nguyen, et al.
Julkaistu: (2020-11-01)

Adjuvant Activity of CpG-Oligonucleotide Administered Transcutaneously in Combination with Vaccination Using a Self-Dissolving Microneedle Patch in Mice
Tekijä: Sachiko Hirobe, et al.
Julkaistu: (2021-12-01)